Jump Financial, LLC Absci Corp Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$2.97 - $4.49 $603,019 - $911,636	-203,037 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$2.92 - $6.58 $441,293 - $994,422	151,128 Added 291.14%	203,037 $625,000
Q1 2024 May 13, 2024	BUY	$3.41 - $5.74 $122,647 - $206,450	35,967 Added 225.61%	51,909 $294,000
Q4 2023 Oct 21, 2024	SELL	$1.15 - $4.79 $215,159 - $896,185	-187,095 Reduced 92.15%	15,942 $66,000
Q4 2023 Feb 07, 2024	BUY	$1.15 - $4.79 $18,333 - $76,362	15,942 New	15,942 $66,000
Q4 2022 Feb 13, 2023	BUY	$2.0 - $3.58 $132,000 - $236,280	66,000 New	66,000 $138,000

130

59.3M

255K

93.6K

Ticker ABSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 92,843,504
Market Cap $269M
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.